Eligibility for EMPEROR trials in a real-world heart failure population: data from the Swedish heart failure registry

Back

HFA Premium Access

Eligibility for EMPEROR trials in a real-world heart failure population: data from the Swedish heart failure registry

Session: Rapid Fire 4 - Chronic heart failure - Pharmacology

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor T. Thorvaldsen (Stockholm, SE)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Tonje Thorvaldsen

Karolinska Institute, Stockholm (Sweden)

1 follower

14 more presentations in this session

Heart failure outcomes in patients with diabetes with and without atrial fibrillation - data from the EMPA-REG OUTCOME study

Speaker: Professor M. Boehm (Homburg, DE)

Metformin reduces myocardial oxygen consumption and improves myocardial efficiency in pre-diabetic heart failure patients

Speaker: Doctor A. Larsen (Herning, DK)

Effects of combined uptitration of ACE-inhibitors and beta-blockers in heart failure with reduced ejection fraction

Speaker: Doctor W. Ouwerkerk (Amsterdam, NL)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in heart failure patients with mid-range and preserved ejection fraction and clinical outcomes: from the KCHF Registry

Speaker: Doctor Y. Yoshikawa (Kyoto, JP)

The role of candesartan or carvedilol for prevention of anthracycline induced subclinical cardiotoxicity in breast cancer patients.

Speaker: Doctor M. Lee (Daejeon, KR)

Access

Abstract

Access the full session

Rapid Fire 4 - Chronic heart failure - Pharmacology

Speakers: Doctor T. Thorvaldsen, Professor M. Boehm, Doctor A. Larsen, Doctor W. Ouwerkerk, Doctor Y. Yoshikawa...

Access

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources